Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice

被引:274
作者
Gnarra, JR
Ward, JM
Porter, FD
Wagner, JR
Devor, DE
Grinberg, A
EmmertBuck, MR
Westphal, H
Klausner, RD
Linehan, WM
机构
[1] NCI,UROL ONCOL BRANCH,DIV CLIN SCI,BETHESDA,MD 20892
[2] NCI,PATHOL LAB,BETHESDA,MD 20892
[3] NCI,OFF DIRECTOR,BETHESDA,MD 20892
[4] NCI,VET & TUMOR PATHOL SECT,OFF LAB ANIM SCI,BETHESDA,MD 20892
[5] NICHHD,LAB MAMMALIAN GENES & DEV,BETHESDA,MD 20892
关键词
D O I
10.1073/pnas.94.17.9102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Inheritance of an inactivated form of the VHL tumor suppressor gene predisposes patients to develop von Hippel-Lindau disease, and somatic VHL inactivation is an early genetic event leading to the development of sporadic renal cell carcinoma, The VHL gene was disrupted by targeted homologous recombination in murine embryonic stem cells, and a mouse line containing an inactivated VHL allele was generated, While heterozygous VHL (+/-) mice appeared phenotypically normal, VHL -/- mice died in utero at 10.5 to 12.5 days of gestation (E10.5 to E12.5). Homozygous VHL -/- embryos appeared to develop normally until E9.5 to E10.5, when placental dysgenesis developed, Embryonic vasculogenesis of the placenta failed to occur in VHL -/- mice, and hemorrhagic lesions developed in the placenta, Subsequent hemorrhage in VHL -/- embryos caused necrosis and death, These results indicate that VHL expression is critical for normal extraembryonic vascular development.
引用
收藏
页码:9102 / 9107
页数:6
相关论文
共 29 条
  • [1] ELONGIN (SIII) - A MULTISUBUNIT REGULATOR OF ELONGATION BY RNA-POLYMERASE-II
    ASO, T
    LANE, WS
    CONAWAY, JW
    CONAWAY, RC
    [J]. SCIENCE, 1995, 269 (5229) : 1439 - 1443
  • [2] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [3] INHIBITION OF TRANSCRIPTION ELONGATION BY THE VHL TUMOR-SUPPRESSOR PROTEIN
    DUAN, DR
    PAUSE, A
    BURGESS, WH
    ASO, T
    CHEN, DYT
    GARRETT, KP
    CONAWAY, RC
    CONAWAY, JW
    LINEHAN, WM
    KLAUSNER, RD
    [J]. SCIENCE, 1995, 269 (5229) : 1402 - 1406
  • [4] Laser capture microdissection
    EmmertBuck, MR
    Bonner, RF
    Smith, PD
    Chuaqui, RF
    Zhuang, ZP
    Goldstein, SR
    Weiss, RA
    Liotta, LA
    [J]. SCIENCE, 1996, 274 (5289) : 998 - 1001
  • [5] Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
    Ferrara, N
    CarverMoore, K
    Chen, H
    Dowd, M
    Lu, L
    OShea, KS
    PowellBraxton, L
    Hillan, KJ
    Moore, MW
    [J]. NATURE, 1996, 380 (6573) : 439 - 442
  • [6] HYPOXIA-INDUCED TRANSCRIPTION OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR GENE IS INDEPENDENT OF FUNCTIONAL AP-1 TRANSCRIPTION FACTOR
    FINKENZELLER, G
    TECHNAU, A
    MARME, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 208 (01) : 432 - 439
  • [7] ROLE OF THE FLT-1 RECEPTOR TYROSINE KINASE IN REGULATING THE ASSEMBLY OF VASCULAR ENDOTHELIUM
    FONG, GH
    ROSSANT, J
    GERTSENSTEIN, M
    BREITMAN, ML
    [J]. NATURE, 1995, 376 (6535) : 66 - 70
  • [8] INSITU HYBRIDIZATION IN HIV RESEARCH
    FOX, CH
    COTTLERFOX, M
    [J]. MICROSCOPY RESEARCH AND TECHNIQUE, 1993, 25 (01) : 78 - 84
  • [9] FOX CH, 1993, PROTOCOLS IMMUNOLOGY
  • [10] GAO JZ, 1995, CANCER RES, V55, P743